Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

SELL
$160.2 - $179.79 $166,928 - $187,341
-1,042 Reduced 47.0%
1,175 $0
Q3 2022

Oct 12, 2022

BUY
$161.33 - $179.52 $806 - $897
5 Added 0.23%
2,217 $362,000
Q2 2022

Jul 27, 2022

BUY
$168.19 - $186.01 $174,413 - $192,892
1,037 Added 88.26%
2,212 $393,000
Q4 2021

Feb 03, 2022

BUY
$155.93 - $173.01 $183,217 - $203,286
1,175 New
1,175 $201,000
Q3 2021

Nov 02, 2021

SELL
$161.5 - $179.47 $214,149 - $237,977
-1,326 Closed
0 $0
Q2 2021

Jul 13, 2021

SELL
$159.48 - $171.07 $702,668 - $753,734
-4,406 Reduced 76.87%
1,326 $218,000
Q1 2021

Apr 12, 2021

SELL
$153.07 - $170.48 $37,961 - $42,279
-248 Reduced 4.15%
5,732 $942,000
Q4 2020

Jan 29, 2021

SELL
$137.11 - $157.38 $188,114 - $215,925
-1,372 Reduced 18.66%
5,980 $941,000
Q3 2020

Oct 20, 2020

BUY
$140.38 - $153.83 $112,304 - $123,064
800 Added 12.21%
7,352 $1.09 Million
Q2 2020

Jul 31, 2020

BUY
$128.81 - $155.51 $64,405 - $77,755
500 Added 8.26%
6,552 $920,000
Q1 2020

Apr 27, 2020

SELL
$111.14 - $153.99 $366,873 - $508,320
-3,301 Reduced 35.29%
6,052 $794,000
Q4 2019

Jan 29, 2020

BUY
$127.5 - $146.44 $5,100 - $5,857
40 Added 0.43%
9,353 $1.36 Million
Q3 2019

Oct 15, 2019

SELL
$126.95 - $142.14 $14,853 - $16,630
-117 Reduced 1.24%
9,313 $1.2 Million
Q2 2019

Jul 12, 2019

SELL
$131.15 - $144.24 $62,952 - $69,235
-480 Reduced 4.84%
9,430 $1.31 Million
Q1 2019

Apr 24, 2019

SELL
$125.72 - $139.79 $304,242 - $338,291
-2,420 Reduced 19.63%
9,910 $1.39 Million
Q4 2018

Jan 14, 2019

BUY
$122.84 - $147.84 $760,256 - $914,981
6,189 Added 100.78%
12,330 $1.59 Million
Q2 2018

Aug 06, 2018

BUY
$119.4 - $131.76 $335,752 - $370,509
2,812 Added 84.47%
6,141 $745,000
Q1 2018

May 08, 2018

BUY
$125.1 - $148.14 $416,457 - $493,158
3,329 New
3,329 $427,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Hms Capital Management, LLC Portfolio

Follow Hms Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hms Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hms Capital Management, LLC with notifications on news.